Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Ozanimod 230microgram capsules |
| Virtual Therapeutic Moiety | Ozanimod |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Combination product | Component only product |
| Prescribing status | Invalid to prescribe in NHS primary care |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | capsule |
| Unit dose unit of measure | capsule |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Ozanimod hydrochloride |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 870525003 |
| Strength value numerator | 230.000 |
| Strength value numerator unit | microgram |
| Ontology Drug Form & Route | |
| Form & Route | capsule.oral |
| Dose Form | |
| Formulation | Oral capsule |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Zeposia 0.23mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) | |
| Virtual Medicinal Product Packs | |
| Ozanimod 230microgram capsules 4 capsule | |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.